BIOIMPACT CAPITAL LLC
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | CNTX | 10.68M | $15.70M |
 | CGEM | 7.65M | $79.16M |
 | TRVI | 3.29M | $41.15M |
 | CRVS | 2.74M | $21.13M |
 | ALMS | 2.40M | $23.44M |
 | RLAY | 2.23M | $18.89M |
 | ENGN | 1.84M | $16.62M |
 | ORIC | 1.80M | $14.71M |
 | EWTX | 1.66M | $41.08M |
 | VTYX | 1.64M | $14.80M |
 | RCKT | 1.59M | $5.57M |
 | DYN | 1.41M | $27.49M |
 | LQDA | 1.40M | $48.32M |
 | HOWL | 1.39M | $883.51K |
 | QURE | 1.38M | $33.06M |
 | SNDX | 1.34M | $28.11M |
 | AGIO | 1.30M | $35.48M |
 | GLUE | 1.17M | $18.40M |
 | DBVT | 997K | $19.11M |
 | URGN | 941K | $22.05M |
Context Therapeutics Inc.
CNTX
Shares Held
10.68M
Value
$15.70M
Cullinan Therapeutics, Inc.
CGEM
Shares Held
7.65M
Value
$79.16M
Trevi Therapeutics, Inc.
TRVI
Shares Held
3.29M
Value
$41.15M
Corvus Pharmaceuticals, Inc.
CRVS
Shares Held
2.74M
Value
$21.13M
Alumis Inc. Common Stock
ALMS
Shares Held
2.40M
Value
$23.44M
Relay Therapeutics, Inc.
RLAY
Shares Held
2.23M
Value
$18.89M
enGene Holdings Inc.
ENGN
Shares Held
1.84M
Value
$16.62M
ORIC Pharmaceuticals, Inc.
ORIC
Shares Held
1.80M
Value
$14.71M
Edgewise Therapeutics, Inc.
EWTX
Shares Held
1.66M
Value
$41.08M
Ventyx Biosciences, Inc.
VTYX
Shares Held
1.64M
Value
$14.80M
Rocket Pharmaceuticals, Inc.
RCKT
Shares Held
1.59M
Value
$5.57M
Dyne Therapeutics, Inc.
DYN
Shares Held
1.41M
Value
$27.49M
Liquidia Corporation
LQDA
Shares Held
1.40M
Value
$48.32M
Werewolf Therapeutics, Inc.
HOWL
Shares Held
1.39M
Value
$883.51K
uniQure N.V.
QURE
Shares Held
1.38M
Value
$33.06M
Syndax Pharmaceuticals, Inc.
SNDX
Shares Held
1.34M
Value
$28.11M
Agios Pharmaceuticals, Inc.
AGIO
Shares Held
1.30M
Value
$35.48M
Monte Rosa Therapeutics, Inc.
GLUE
Shares Held
1.17M
Value
$18.40M
DBV Technologies S.A.
DBVT
Shares Held
997K
Value
$19.11M
UroGen Pharma Ltd.
URGN
Shares Held
941K
Value
$22.05M